 | Up a level |
Bertucci, François; Ng, Kiu Yan Charlotte; Patsouris, Anne; Droin, Nathalie; Piscuoglio, Salvatore; Carbuccia, Nadine; Soria, Jean Charles; Dien, Alicia Tran; Adnani, Yahia; Kamal, Maud; Garnier, Séverine; Meurice, Guillaume; Jimenez, Marta; Dogan, Semih; Verret, Benjamin; Chaffanet, Max; Bachelot, Thomas; Campone, Mario; Lefeuvre, Claudia; Bonnefoi, Herve; ... (2019). Genomic characterization of metastatic breast cancers. Nature, 569(7757), pp. 560-564. Springer Nature 10.1038/s41586-019-1056-z
Loi, Sherene; Giobbie-Hurder, Anita; Gombos, Andrea; Bachelot, Thomas; Hui, Rina; Curigliano, Giuseppe; Campone, Mario; Biganzoli, Laura; Bonnefoi, Hervé; Jerusalem, Guy; Bartsch, Rupert; Rabaglio, Manuela-Poretti; Kammler, Roswitha; Maibach, Rudolf; Smyth, Mark J; Di Leo, Angelo; Colleoni, Marco; Viale, Giuseppe; Regan, Meredith M and André, Fabrice (2019). Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial. The lancet oncology, 20(3), pp. 371-382. Elsevier 10.1016/S1470-2045(18)30812-X
Decensi, Andrea; Sun, Zhuoxin; Guerrieri-Gonzaga, Aliana; Thürlimann, Beat; McIntosh, Christina; Tondini, Carlo; Monnier, Alain; Campone, Mario; Debled, Marc; Schönenberger, Astrid; Zaman, Khalil; Johansson, Harriet; Price, Karen N; Gelber, Richard D.; Goldhirsch, Aron; Coates, Alan S.; Aebi, Stefan (2014). Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences. Breast cancer research and treatment, 144(2), pp. 321-329. Springer 10.1007/s10549-014-2849-2
